Money Today's '2021 Korea Industry Awards' awards ceremony held at the Korea Press Center in Jung-gu, Seoul on the afternoon of the 12th. / Photo = Reporter Lee Ki-beom leekb@

Sung-ho Han, CEO of AdipoLABs (right in photo), is taking a commemorative photo with Hee-kyung Jeong, Executive Director of Money Today, after receiving the 'First in Class Award' at the '2021 7th Korea Industry Awards' hosted by Money Today held at the Korea Press Center on the 12th.

AdipoLABs is a company that has obtained CE (European Certification Mark) and Malaysian MDA (Medical Device Approval) for its high-frequency-based hyperthermia cancer treatment medical device, REMISSION 1℃. REMISSION 1℃ is a medical device that can relieve pain through deep heat by raising body temperature above 40℃. It has the effect of improving blood circulation and immunity. The device is distributed close to 80 medical institutions, including Seoul St. Mary's Hospital of the Catholic University of Korea. The company said, “We expect our export to reach its momentum after the end of the coronavirus pandemic,” and added, “Cancer treatment devices developed with our technology will contribute to the health of global citizens.”

Reporter Lee Yu-mi youme@

Source: AdipoLABs, hyperthermia cancer treatment device ‘First in Class’ selected (naver.com)